文献速递临床微生物分子诊断临床免疫

明尼苏达州临床空肠弯曲菌分离株的毒力与耐药全基因组特征分析(2018-2021)

Whole genome-based characterization of virulence and antimicrobial resistance determinants in clinical Campylobacter jejuni isolates from Minnesota, 2018-2021.
PubMed 文献 · J Clin Microbiol · 2026-10-27

研究对2018至2021年明尼苏达州2783株临床空肠弯曲菌分离株进行全基因组测序,分析毒力与耐药基因特征,并将部分菌株的基因型耐药谱与表型药敏结果比较。结果显示四环素耐药最常见(52.3%),喹诺酮类耐药占30.7%,大环内酯类(2.4%)和氨基糖苷类(1.8%)耐药少见;基因型与表型总体相关性好,但存在24处不一致。

要点

  • 四环素耐药率52.3%,喹诺酮类耐药率30.7%,大环内酯类和氨基糖苷类耐药少见。
  • 29%菌株携带5种与喹诺酮耐药相关的gyrA点突变,以T861替换最常见。
  • 全基因组测序与表型药敏总体一致性良好,但存在24处不一致,需关注未知耐药机制。

核心结论

  • 全基因组测序有助于改善空肠弯曲菌耐药监测并理解毒力相关因子,支持将其整合到常规监测中。

研究设计与样本

  • 对2018至2021年明尼苏达州居民临床空肠弯曲菌分离株(n=2783)进行全基因组测序。
  • 分离株来源:98.4%粪便、1.2%来源不明、0.4%血液、1份直肠拭子。
  • 对部分分离株进行表型药敏试验,比较基因型与表型耐药谱的一致性。

主要发现

  • 超过90%的分离株携带应激防御(rpoN和htrB)、细胞致死性膨胀毒素(cdtA、cdtB和cdtC)及细胞黏附侵袭(ciaB、cadF和flaC)相关基因。
  • 检出多种耐药基因,β-内酰胺类耐药基因流行率尤其高。
  • 29%的分离株存在5种与喹诺酮耐药相关的gyrA点突变,T861替换最常见。
  • 表型耐药:四环素52.3%、喹诺酮类30.7%、大环内酯类2.4%、氨基糖苷类1.8%。
  • 基因型与表型总体强相关(尤其四环素和喹诺酮类),但发现24处不一致;其中21处表型耐药而基因组无耐药标记,3处携带tet(O)基因但表型敏感。

临床怎么用

  • 全基因组测序可用于空肠弯曲菌耐药监测和毒力因子分析,支持纳入常规监测。
  • 基因型耐药预测与表型药敏总体一致,但需注意不一致情况,尤其表型耐药而基因型未检出耐药标记时。
  • 区域监测数据可为公共卫生决策和抗菌药物管理提供基线参考。

局限性

  • 表型药敏试验仅对部分分离株进行。
  • 21处不一致中基因组耐药标记缺失,提示可能存在未知耐药机制或当前测序分析方法的局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Campylobacter jejuni is a leading cause of foodborne gastroenteritis globally and is classified by the Centers for Disease Control and Prevention as a serious public health threat due to increasing resistance to fluoroquinolones and macrolides. This study used whole-genome sequencing to characterize the virulence and antimicrobial resistance profiles of 2,783 clinical C. jejuni isolates (98.4% stool, 1.2% unknown source, 0.4% blood, and one from rectal swab) collected from Minnesota residents from 2018 through 2021. More than 90% of the isolates had genes related to stress defense (rpoN and htrB), cytolethal distending toxin (cdtA, cdtB, and cdtC), and cell adhesion and invasion (ciaB, cadF, and flaC). A diverse array of antimicrobial resistance genes were detected, with beta-lactam resistance genes having a particularly high prevalence. Five gyrA point mutations associated with quinolone resistance were present in 29% of isolates, with the T861 substitution being the most prevalent. Phenotypically, tetracycline resistance was most common (52.3%), followed by quinolone resistance (30.7%), while resistance to other antimicrobial classes-macrolide (2.4%) and aminoglycoside (1.8%)-was uncommon. To evaluate the correlation between genotypic and phenotypic antimicrobial resistance profiles, the antimicrobial susceptibility testing results from a subset of isolates were compared with genotypic resistance profiles. The results showed a strong overall correlation, particularly for tetracycline and quinolones, though 24 discrepancies were detected. In the majority of discrepancies (n = 21), genomic antimicrobial resistance markers were absent in isolates that were phenotypically resistant, suggesting possible unknown resistance mechanisms or limitations in current sequencing analysis methods. The remaining three discrepancies occurred in isolates that had the tet(O) resistance gene but were susceptible to tetracycline phenotypically. These findings highlight the value of whole-genome sequencing in improving antimicrobial resistance surveillance and understanding virulence-associated factors in C. jejuni, supporting its integration into routine monitoring practices to better manage and understand antimicrobial resistance in foodborne pathogens.IMPORTANCEThis study characterizes the virulence and antimicrobial resistance profiles of Campylobacter isolates using whole-genome sequencing (WGS) data generated through routine foodborne disease surveillance. A subset of isolates was also tested for phenotypic antimicrobial susceptibility testing, allowing us to evaluate resistance patterns and assess genotype-phenotype concordance. This comparison provides important evidence regarding the reliability and limitations of using WGS-detected resistance determinants to predict antimicrobial susceptibility. The 5 years of accumulated surveillance data provide a comprehensive, population-level understanding of circulating Campylobacter strains in Minnesota, USA, and establish an important regional baseline for monitoring changes over time. These findings can be compared with national surveillance data to identify geographic similarities and differences and provide a valuable regional context for public health decision-making and antimicrobial stewardship.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Hwang H, Orth M, Jawahir S, et al. Whole genome-based characterization of virulence and antimicrobial resistance determinants in clinical Campylobacter jejuni isolates from Minnesota, 2018-2021. J Clin Microbiol. 2026. PMID: 42937302. doi:10.1128/jcm.00514-26

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。